Articles Published in 2013

Study concludes Stretta is desirable GERD treatment

Tuesday, September 10, 2013 01:00 PM

A newly published peer-review study that examines Stretta therapy is bringing renewed attention to this non-surgical procedure that has 10 years of patient data and recently earned The Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) highest GRADE recommendation.

More... »

Novella Clinical announces new leadership roles

Tuesday, September 10, 2013 12:00 PM

Three senior executives of CRO Novella Clinical have assumed new leadership roles within the organization.

More... »

Rigel refocuses resources, cuts 30 jobs

Tuesday, September 10, 2013 11:01 AM

Rigel Pharmaceuticals plans to focus resources on the completion of three lead clinical programs. These efforts include a phase III clinical study of fostamatinib, an oral SYK inhibitor, in Immune Thrombocytopenic Purpura (ITP), pending discussions with regulatory agencies. Rigel believes that a phase III clinical program would encompass approximately 150 patients and can be completed in 2015.

More... »

AMRI announces executive leadership changes

Tuesday, September 10, 2013 10:01 AM

CRO Albany Molecular Research has announced Thomas E. D'Ambra, Ph.D., will retire as president and chief executive officer, effective Dec. 31. D'Ambra will be named non-executive chairman of the board of directors on the same date.

More... »

CROS NT acquires Stat-Tech Services

Tuesday, September 10, 2013 09:02 AM

International CRO CROS NT, which specializes in biometrics services, has acquired Stat‐Tech Services, a Chapel Hill, N.C.-based CRO with experience in the medical devices sector. Financial terms of the transaction were not disclosed.

More... »

Debiopharm, TCG Lifesciences collaborate to develop antibiotics

Monday, September 9, 2013 03:51 PM

Debiopharm Group, a Swiss-based global biopharmaceutical company focused on development of prescription drugs that target unmet medical needs and companion diagnostics, and TCG Lifesciences, a CRO in early drug discovery and development, have inked an exclusive discovery collaboration to develop antibiotics targeting drug-resistant bacteria for community hospital-acquired infections.

More... »

Baxter acquires Gambro

Monday, September 9, 2013 03:49 PM

Baxter International has acquired Sweden-based Gambro, a privately-held global medical technology company and producer of dialysis products.

More... »

BioReliance opens U.S. clearance services laboratories

Monday, September 9, 2013 12:08 PM

Sigma-Aldrich BioReliance, the biologics and early-development services business under SAFC, has opened a new clearance services facility in Rockville, Md.

More... »

Biogen Idec, Isis Pharmaceuticals collaborate on neurological disorders

Monday, September 9, 2013 12:07 PM

Biogen Idec and Isis Pharmaceuticals have entered a broad, six-year research collaboration to leverage antisense technology to advance the treatment of neurological diseases. The agreement combines Biogen Idec's experience in neurology with Isis' antisense technology to develop novel therapies to treat neurological disorders.

More... »

Nuclea Biotechnologies acquires Oncogene Science, extends Wilex cooperation

Monday, September 9, 2013 12:05 PM

Pittsfield, Mass.-based Nuclea Biotechnologies has acquired all shares of Cambridge, Mass.-based Wilex (Oncogene Science), a wholly owned U.S. subsidiary of Wilex.

More... »